Seroxat study under-reported harmful effects on young people, say scientists

Experts who re-analysed data say study is still referred to in medical literature and needs to be retracted

An influential study which claimed that an antidepressant drug was safe for children and adolescents failed to report the true numbers of young people who thought of killing themselves while on it, re-analysis of the trial has found

Study 329, into the effects of GlaxoSmithKline's drug paroxetine on under-18s, was published in 2001 and later found to be flawed. In 2003, the UK drug regulator instructed doctors not to prescribe paroxetine - sold as Seroxat in the UK and Paxil in the US - to adolescents.